{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:12:42Z","timestamp":1758636762154,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.pcad.2020.01.001","type":"journal-article","created":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T02:19:04Z","timestamp":1578536344000},"page":"74-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["PCVD 2020"],"prefix":"10.1016","volume":"63","author":[{"given":"Carl J.","family":"Lavie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2020.01.001_bb0005","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pcad.2019.07.002","article-title":"Continuing with good statistics at progress in cardiovascular diseases","volume":"62","author":"Lavie","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pcad.2019.03.001","article-title":"Exercise in medicine","volume":"62","author":"Rognmo","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pcad.2019.08.005","article-title":"Emerging strategies for diabetes and cardiovascular disorders: introduction and foreword","volume":"62","author":"Deedwania","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0020","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pcad.2019.11.006","article-title":"Lipid update 2020: introduction and foreword","volume":"62","author":"Robinson","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pcad.2019.01.002","article-title":"Cardiorespiratory fitness and cardiovascular disease: the past, present, and future","volume":"62","author":"Kaminsky","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pcad.2019.02.003","article-title":"Are the neuroprotective effects of exercise training systemically mediated?","volume":"62","author":"Tari","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0035","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pcad.2019.02.004","article-title":"Global physical activity levels: need for intervention","volume":"62","author":"Ozemek","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pcad.2019.01.004","article-title":"Guidelines for the delivery and monitoring of high intensity interval training in clinical populations","volume":"62","author":"Taylor","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0045","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pcad.2018.12.003","article-title":"The association between the change in directly measured cardiorespiratory fitness across time and mortality risk","volume":"62","author":"Imboden","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0050","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pcad.2019.03.002","article-title":"Exercise reveals proline dehydrogenase as a potential target in heart failure","volume":"62","author":"Moreira","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0055","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pcad.2018.09.002","article-title":"Temporal changes in a novel metric of physical activity tracking (personal activity intelligence) and mortality: the HUNT Study, Norway","volume":"62","author":"Kieffer","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0060","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pcad.2019.02.006","article-title":"Personal activity intelligence (PAI): a new standard in activity tracking for obtaining a healthy cardiorespiratory fitness level and low cardiovascular risk","volume":"62","author":"Nauman","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pcad.2018.08.006","article-title":"Meta-analysis of exercise training on left ventricular ejection fraction in heart failure with reduced ejection fraction: a 10-year update","volume":"62","author":"Tucker","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0070","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pcad.2019.02.007","article-title":"A role for FNDC5\/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases","volume":"62","author":"Young","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pcad.2019.07.006","article-title":"An update on pharmacotherapies in diabetic dyslipidemia","volume":"62","author":"Gupta","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pcad.2019.03.003","article-title":"Diabetic cardiomyopathy: a comprehensive updated review","volume":"62","author":"Murtaza","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0085","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pcad.2019.08.004","article-title":"Obesity, risk of diabetes and role of physical activity, exercise training and cardiorespiratory fitness","volume":"62","author":"Carbone","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0090","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.pcad.2019.08.003","article-title":"Cardiovascular outcome trials of the newer anti-diabetic medications","volume":"62","author":"Acharya","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pcad.2019.07.005","article-title":"Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes","volume":"62","author":"Garg","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pcad.2019.07.004","article-title":"The role of coronary artery bypass surgery versus percutaneous intervention in patients with diabetes and coronary artery disease","volume":"62","author":"Godoy","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0105","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.pcad.2019.08.001","article-title":"The elephant in the room: why cardiologists should stop ignoring type 2 diabetes","volume":"62","author":"O\u2019Keefe","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pcad.2019.07.003","article-title":"Diabetes, heart failure, and renal dysfunction: the vicious circles","volume":"62","author":"Braunwald","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pcad.2019.11.005","article-title":"The 2018 AHA\/ACC\/multi-society cholesterol guidelines: looking at past, present and future","volume":"62","author":"Stone","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0120","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.pcad.2019.10.004","article-title":"Lipid management beyond the guidelines","volume":"62","author":"Robinson","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0125","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.pcad.2019.10.005","article-title":"New insights into managing symptoms during statin therapy","volume":"62","author":"Robinson","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.pcad.2019.11.003","article-title":"Implications for REDUCE IT in clinical practice","volume":"62","author":"Bittner","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0135","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.pcad.2019.11.007","article-title":"Impact of fitness and changes in fitness on lipids and survival","volume":"62","author":"Lavie","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pcad.2018.07.009","article-title":"Introduction and update on obesity and cardiovascular diseases 2018","volume":"61","author":"Ortega","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0145","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pcad.2018.07.004","article-title":"The joint association of fitness and fatness on cardiovascular disease mortality: a meta-analysis","volume":"61","author":"Barry","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0150","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pcad.2018.07.008","article-title":"Role of physical activity and fitness in the characterization and prognosis of the metabolically healthy obesity phenotype: a systematic review and meta-analysis","volume":"61","author":"Ortega","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0155","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pcad.2018.06.002","article-title":"The contributions of \u201cdiet\u201d, \u201cgenes\u201d, and physical activity to the etiology of obesity: contrary evidence and consilience","volume":"61","author":"Archer","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0160","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pcad.2018.07.003","article-title":"An overview and update on obesity and the obesity paradox in cardiovascular diseases","volume":"61","author":"Elagizi","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0165","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pcad.2018.06.004","article-title":"Overview of epidemiology and contribution of obesity and body fat distribution to cardiovascular disease: an update","volume":"61","author":"Pich\u00e9","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pcad.2018.07.012","article-title":"Obesity and cardiac remodeling in adults: mechanisms and clinical implications","volume":"61","author":"Alpert","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pcad.2018.05.001","article-title":"Dietary prevention of cardiovascular diseases","volume":"61","author":"Sievenpiper","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0180","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pcad.2018.04.006","article-title":"Mediterranean diet and cardiovascular disease prevention: what do we know?","volume":"61","author":"Salas-Salvad\u00f3","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pcad.2018.04.007","article-title":"In defense of sugar: a critique of diet-centrism","volume":"61","author":"Archer","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pcad.2018.02.002","article-title":"Coffee for cardioprotection and longevity","volume":"61","author":"O\u2019Keefe","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0195","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pcad.2018.02.001","article-title":"Alcohol and CV health: Jekyll and Hyde J-curves","volume":"61","author":"O\u2019Keefe","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2020.01.001_bb0200","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.pcad.2018.11.005","article-title":"An update on the role of cardiorespiratory fitness, structured exercise and lifestyle physical activity in preventing cardiovascular disease and health risk","volume":"61","author":"Ozemek","year":"2018","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062020300116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062020300116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:16:51Z","timestamp":1758500211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062020300116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0033062020300116"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2020.01.001","relation":{},"ISSN":["0033-0620"],"issn-type":[{"type":"print","value":"0033-0620"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCVD 2020","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2020.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}